Nasdaq IPOs

Churchill Capital Corp VI, the sixth blank check company founded by dealmaker and former Citi executive Michael Klein, raised $480 million by offering 48 million units at $10. The company offered 8 million more units than anticipated. Each unit consists of one share of commo

Bite Acquisition, a blank check company targeting the restaurant sector in North America, raised $175 million by offering 17.5 million units at $10. The company offered 2.5 million more units than anticipated. Each unit consists of one share of common stock and one-half of a

Catcha Investment, a blank check company formed by Catcha Group targeting "new economy" sectors in Asia Pacific, raised $275 million by offering 27.5 million units at $10. The company offered 2.5 million more units than anticipated. Each unit will consist of one share of com

Tishman Speyer Innovation II, the second blank check company formed by Tishman Speyer targeting real estate and property technology businesses, raised $300 million by offering 30 million units at $10. The company offered 5 million more units than anticipated. Each unit consi

Rosecliff Acquisition I, a blank check company backed by Rosecliff Venture Management targeting technology, raised $220 million by offering 22 million units at $10. The company offered 2 million more units than anticipated. Each unit will consist of one share of common stock and

urban-gro, which provides equipment and services for the commercial indoor horticulture market, raised $54 million by offering 5.4 million shares at $10 in its Nasdaq uplisting. At pricing, it commands a diluted market cap of about $103 million. The company originally filed to r

NexImmune, a Phase 1/2 biotech developing T cell immunotherapies for cancer, raised $110 million by offering 6.5 million shares at $17, the high end of the range of $15 to $17. NexImmune originally filed to sell 4.7 million shares, before increasing the offering to 5.9 milli

Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, raised $221 million by offering 13.8 million shares at $16, the high end of the $14 to $16 range. Talis originally filed to sell 10 million shares, before increasing the offering to

Social Leverage Acquisition I, a blank check company led by Social Leverage's Howard Lindzon targeting the tech and fintech sectors, raised $300 million by offering 30 million units at $10. Each unit consists of one share of common stock and one-fourth of a warrant, exercisable

Decibel Therapeutics, which is developing preclinical gene therapies for hearing loss and balance disorders, raised $127 million by offering 7.1 million shares at $18, the high end of the range of $16 to $18. The company had originally filed to sell 5.9 million shares. Decibel Th

Roblox, an online platform where users can develop and play video games, reported its restated financial results for the nine months ended September 30, 2020, in an amendment filed with the SEC on Thursday. Roblox originally filed for a $1 billion IPO in November 2020, but inst

Protagenic Therapeutics, an early stage biotech developing therapies for stress-related neuropsychiatric and mood disorders, filed on Thursday with the SEC to raise up to $18 million in an initial public offering. The company is currently listed on the OTCQB (PTIX). The company

Atlantic Coastal Acquisition, a blank check company targeting the next-generation mobility sector, filed on Thursday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million units at

Flora Growth, a Canadian producer of natural medicinal-grade cannabis products, filed on Thursday with the SEC for initial public offering. The company did not specify a deal size, though we estimate that it could raise up to $15 million. Flora cultivates and processes natural m

Arrowroot Acquisition, a blank check company formed by Arrowroot Capital targeting enterprise software, filed on Thursday with the SEC to raise up to $250 million in an initial public offering. The Marina Del Rey, CA-based company plans to raise $250 million by offering 25 milli

Goal Acquisitions, a blank check company targeting the sports and media sectors, raised $225 million by offering 22.5 million units at $10. Each unit consists of one share of common stock and one warrant, exercisable at $11.50. Affiliates of Atalaya Capital Management had in

Roth CH Acquisition III, the third blank check company formed by executives at Roth Capital and Craig-Hallum, raised the proposed deal size for its upcoming IPO on Thursday. The Newport Beach, CA-based company now plans to raise $150 million by offering 15 million units at $10.

NexImmune, a Phase 1/2 biotech developing T cell immunotherapies for cancer, raised the proposed deal size for its upcoming IPO on Thursday. The Gaithersburg, MD-based company now plans to raise $94 million by offering 5.9 million shares at a price range of $15 to $17. The compa

AFC Gamma, a newly-formed commercial mortgage REIT focused on the cannabis industry, raised the proposed deal size for its upcoming IPO on Thursday. The West Palm Beach, FL-based company now plans to raise $119 million by offering 6.3 million shares at $19. The company had previ

Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, raised the proposed deal size for its upcoming IPO on Thursday. The Menlo Park, CA-based company now plans to raise $173 million by offering 11.5 million shares at a price range of